Kristien Boelaert

1 - 20 out of 166Page size: 20

Publications

  1. 2019
  2. Published

    A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy

    Martin Read, Alice Fletcher, Luke Alderwick, Kristien Boelaert, Vicki Smith & Christopher McCabe, 13 Nov 2019, In : Endocrine Abstracts. 65, 1 p., OC4.1.

    Research output: Contribution to journal › Abstract

  3. Published

    Levothyroxine to increase live births in euthyroid women with thyroid antibodies trying to conceive: the TABLET RCT

    Lee Middleton, Versha Cheed & 14 others, , Alex Tan, Mark Kilby, Kristien Boelaert, Jane Daniels, Shakila Thangaratinam & Arri Coomarasamy, 31 Oct 2019, In : Efficacy and Mechanism Evaluation. 6, 11, p. 1-102 102 p.

    Research output: Contribution to journal › Article

  4. E-pub ahead of print

    Targeting novel sodium iodide symporter interactors ADP-ribosylation factor 4 (ARF4) and valosin-containing protein (VCP) enhances radioiodine uptake: Targeting NIS interactors to enhance radioiodine uptake

    Alice Fletcher, Martin Read, Dean Larner, Hannah Nieto, Gareth Lavery, Kristien Boelaert, Andrew Turnell, Vicki Smith & Christopher McCabe, 31 Oct 2019, In : Cancer Research.

    Research output: Contribution to journal › Article

  5. Published

    Patients treated for hyperthyroidism are at increased risk of becoming obese: findings from a large prospective secondary care cohort

    Barbara Torlinska & Kristien Boelaert, 15 Oct 2019, In : Thyroid. 29, 10, p. 1380-1389 10 p.

    Research output: Contribution to journal › Article

  6. Published

    Dimerization of the sodium/iodide symporter

    Alice Fletcher, Jonathan Wolf Mueller, David Hodson, Kristien Boelaert, Martin Read, Vicki Smith & Christopher McCabe, Oct 2019, In : Thyroid. 29, 10, p. 1485-1498 14 p.

    Research output: Contribution to journal › Article

  7. Published

    Thyroid replacement therapy, thyroid stimulating hormone levels and long-term health outcomes in patients with hypothyroidism: a longitudinal study

    Rasiah Thayakaran, Nicola Adderley, Barbara Torlinska, Kristien Boelaert, Dana Sumilo, Malcolm Price, G Neil Thomas & Krishnarajah Nirantharakumar, 3 Sep 2019, In : BMJ. 366, l4892.

    Research output: Contribution to journal › Article

  8. Published

    Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease

    Kristien Boelaert & Krishnarajah Nirantharakumar, 1 Aug 2019, In : Clinical Endocrinology. 91, 2, p. 323-330 8 p.

    Research output: Contribution to journal › Article

  9. Published

    Antigen-specific immunotherapy with thyrotropin receptor peptides in Graves' hyperthyroidism: a phase I study

    Kristien Boelaert, 17 Jul 2019, In : Thyroid. 29, 7, p. 1003-1011 9 p.

    Research output: Contribution to journal › Article

  10. Published

    Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management

    Kristien Boelaert & Lorraine Harper, 6 May 2019, In : BMC Nephrology. 20, 1, 154.

    Research output: Contribution to journal › Article

  11. Published

    Knowledge of thyroid eye disease in Graves’ Disease patients with and without orbitopathy

    Matthew Edmunds & Kristien Boelaert, 9 Apr 2019, In : Thyroid. 29, 4, p. 557-562 6 p.

    Research output: Contribution to journal › Article

  12. Published

    Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception

    Rima Smith, Lee Middleton, Versha Cheed, Christopher McCabe & 14 others, , Alex Tan, Mark Kilby, Kristien Boelaert, Jane Daniels, Shakila Thangaratinam & Arri Coomarasamy, 4 Apr 2019, In : The New England Journal of Medicine. 380, p. 1316-1325 10 p.

    Research output: Contribution to journal › Article

  13. Published

    Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial

    Kristien Boelaert, 21 Jan 2019, In : BMJ open. 9, 1, 10 p., e024705.

    Research output: Contribution to journal › Article

  14. Published

    Liothyronine cost and prescriptions in England

    Kristien Boelaert, 1 Jan 2019, In : The Lancet Diabetes and Endocrinology. 7, 1, p. 11-12 2 p.

    Research output: Contribution to journal › Letter

  15. 2018
  16. Published

    Biochemical analysis of radioiodine uptake enhancement in endocrine cancer

    Alice Fletcher, Hannah Nieto, Martin Read, Kristien Boelaert, Christopher McCabe & Vicki Smith, 1 Nov 2018, In : Endocrine Abstracts. 59, 1 p., OC2.4.

    Research output: Contribution to journal › Article

  17. Published

    Oncogenic action of pituitary-tumor transforming gene (PBF) in head and neck cancer is associated with poorer overall survival

    Martin Read, Alice Fletcher, Hannah Nieto, Moray Campbell, Kristien Boelaert, Andrew Turnell, Vicki Smith, Hisham Mehanna & Christopher McCabe, 1 Nov 2018, In : Endocrine Abstracts. 59, 1 p., P119.

    Research output: Contribution to journal › Abstract

  18. Published

    Homozygous loss-of-function mutations in SLC26A7 cause goitrous congenital hypothyroidism

    Hakan Cangul, Kristien Boelaert & 7 others, , Timothy Barrett, Eamonn Maher, 18 Oct 2018, In : JCI Insight. 3, 20, 11 p., e99631.

    Research output: Contribution to journal › Abstract

  19. E-pub ahead of print

    PTTG and PBF functionally interact with p53 and predict overall survival in head and neck cancer

    Martin Read, Alice Fletcher, Peter Rae, Hannah Nieto, Sally Roberts, Moray Campbell, Kristien Boelaert, Andrew Turnell, Vicki Smith, Hisham Mehanna & Christopher McCabe, 28 Aug 2018, In : Cancer Research. 25 p.

    Research output: Contribution to journal › Article

  20. Published

    PO-124 PTTG and PBF functionally interact with P53 and predict overall survival in head and neck cancer

    Martin Read, Alice Fletcher, Kristien Boelaert, Andrew Turnell, Vicki Smith, Hisham Mehanna & Christopher McCabe, 1 Jul 2018, In : ESMO Open. 3, Suppl. 2, p. A69-A69 1 p.

    Research output: Contribution to journal › Abstract

  21. Published

    Yellow fluorescent protein (YFP) as a biosensor for intracellular iodide in thyroid cancer cells

    Martin Read, Alice Fletcher, Kristien Boelaert, Vicki Smith & Christopher McCabe, 15 May 2018.

    Research output: Contribution to conference (unpublished) › Abstract

  22. Published

    The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review

    Jennifer Bryant, Nikos Batis, Rachel Spruce, Christopher McCabe, Kristien Boelaert, Neil Sharma & Hisham Mehanna, 30 Apr 2018, In : Frontiers in Oncology. 8, APR, 132.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 9 Next